Telemedicine in High-Risk Cardiovascular Patients Post-ACS

NACompletedINTERVENTIONAL
Enrollment

337

Participants

Timeline

Start Date

January 6, 2022

Primary Completion Date

February 28, 2025

Study Completion Date

May 31, 2025

Conditions
Cardiovascular DiseasesAcute Coronary Syndrome
Interventions
OTHER

Active Arm

Patient develops possible cardiac symptoms, takes an ECG, BP and oxygen saturation as per their training. Patient will receive a phone call by the trial cardiologist who will have access to a high-quality ECG trace, as well as blood pressure and oxygen saturations, and coupled with the clinical history, can decide on the most appropriate course of further management. With remote follow up over the phone at 3, 6 and 9 months.

OTHER

Control Arm

Standard routine clinical care will be carried out, with remote follow up over the phone at 3, 6 and 9 months.

Trial Locations (1)

W12 0NN

Imperial College Healthcare NHS Trust, London

All Listed Sponsors
collaborator

King Khalid University

OTHER

lead

Imperial College London

OTHER

NCT05015634 - Telemedicine in High-Risk Cardiovascular Patients Post-ACS | Biotech Hunter | Biotech Hunter